These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


201 related items for PubMed ID: 5495326

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effects of dipyridamole on proteinuria in chronic glomerulonephritis and the nephrotic syndrome.
    Ishikawa H, Honjo A, Hayashi M, Hamaguchi T, Morita T, Shindo T, Tetsutani T, Yamamoto T, Okubo H, Oka G.
    Arzneimittelforschung; 1982; 32(3):301-9. PubMed ID: 7200790
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Results of immunodepressive treatment in the nephrotic syndrome.
    Pachiolo R, Genova R.
    Helv Paediatr Acta; 1970 Jan; 25(1):50-8. PubMed ID: 5438807
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Prognosis of nephrosis].
    Habib R, Kleinknecht C, Gubler MC, Levy M, Guillot M, Gagnadoux MF, Broyer M.
    Bol Med Hosp Infant Mex; 1981 Jan; 38(3):447-55. PubMed ID: 7271976
    [Abstract] [Full Text] [Related]

  • 27. [Immunosuppressive treatment of chronic hepatitis].
    Magyar I.
    Dtsch Z Verdau Stoffwechselkr; 1970 Jan; 30(1):31-4. PubMed ID: 5501423
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Cyclosporin A in glomerular diseases].
    Brodehl J.
    Internist (Berl); 1985 Sep; 26(9):578-9. PubMed ID: 3905681
    [No Abstract] [Full Text] [Related]

  • 30. [Methylprednisolone in pulsed doses in chronic glomerulopathies and in nephrotic syndrome with minimal change].
    Matousovic K, Prát V, Kuzemová L, Zástava V.
    Vnitr Lek; 1988 Mar; 34(3):262-9. PubMed ID: 3369099
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Indomethacin in the treatment of glomerulonephritis].
    Tomilina NA, Biriukova LS.
    Sov Med; 1983 Mar; (9):104-6. PubMed ID: 6648668
    [No Abstract] [Full Text] [Related]

  • 34. Cytostatic treatment of glomerular diseases. II. Effect of azathioprine on serum and urine proteins. Report from a Copenhagen Study Group of Renal Diseases.
    Balslov JT, Brun C, Jensen KB, Jorgensen F, Jorgensen HE, Larsen M, Lorenzen I, Thomsen AC.
    Acta Med Scand; 1973 Jun; 193(6):493-8. PubMed ID: 4721958
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Perspectives of indomethacin therapy in glomerular nephropathies].
    Vercellone A, Piccoli G, Ragni R, Cavalli PL.
    Minerva Nefrol; 1969 Jun; 16(2):163-74. PubMed ID: 5398502
    [No Abstract] [Full Text] [Related]

  • 37. [Therapy of the nephrotic syndrome in children].
    Linneweh F.
    Minerva Med; 1973 Oct 27; 64(76):4007-9. PubMed ID: 4764071
    [No Abstract] [Full Text] [Related]

  • 38. [Use of cyclophosphamide in membranoproliferative glomerulonephritis].
    Wills H, Villarreal H.
    Arch Inst Cardiol Mex; 1976 Oct 27; 46(6):770-5. PubMed ID: 1023835
    [Abstract] [Full Text] [Related]

  • 39. The clinical features and prognosis of patients with normocomplementemic mesangiocapillary glomerulonephritis.
    Cameron JS, Ogg CS, White RH, Glasgow EF.
    Clin Nephrol; 1973 Oct 27; 1(1):8-13. PubMed ID: 4767355
    [No Abstract] [Full Text] [Related]

  • 40. Proteinuria and glomerular disease in Jamaica.
    Morgan AG, Shah DJ, Williams W, Forrester TE.
    Clin Nephrol; 1984 Apr 27; 21(4):205-9. PubMed ID: 6733987
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.